Hillier T A, Fryburg D A, Jahn L A, Barrett E J
Division of Endocrinology and Metabolism, Department of Internal Medicine, and General Clinical Research Center, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
Am J Physiol. 1998 Jun;274(6):E1067-74. doi: 10.1152/ajpendo.1998.274.6.E1067.
Insulin clearly stimulates skeletal muscle protein synthesis in vitro. Surprisingly, this effect has been difficult to reproduce in vivo. As in vitro studies have typically used much higher insulin concentrations than in vivo studies, we examined whether these concentration differences could explain the discrepancy between in vitro and in vivo observations. In 14 healthy volunteers, we raised forearm insulin concentrations 1,000-fold above basal levels while maintaining euglycemia for 4 h. Amino acids (AA) were given to either maintain basal arterial (n = 4) or venous plasma (n = 6) AA or increment arterial plasma AA by 100% (n = 4) in the forearm. We measured forearm muscle glucose, lactate, oxygen, phenylalanine balance, and [3H]phenylalanine kinetics at baseline and at 4 h of insulin infusion. Extreme hyperinsulinemia strongly reversed postabsorptive muscle's phenylalanine balance from a net release to an uptake (P < 0.001). This marked anabolic effect resulted from a dramatic stimulation of protein synthesis (P < 0.01) and a modest decline in protein degradation. Furthermore, this effect was seen even when basal arterial or venous aminoacidemia was maintained. With marked hyperinsulinemia, protein synthesis increased further when plasma AA concentrations were also increased (P < 0.05). Forearm blood flow rose at least twofold with the combined insulin and AA infusion (P < 0.01), and this was consistent in all groups. These results demonstrate an effect of high concentrations of insulin to markedly stimulate muscle protein synthesis in vivo in adults, even when AA concentrations are not increased. This is similar to prior in vitro reports but distinct from physiological hyperinsulinemia in vivo where stimulation of protein synthesis does not occur. Therefore, the current findings suggest that the differences in insulin concentrations used in prior studies may largely explain the previously reported discrepancy between insulin action on protein synthesis in adult muscle in vivo vs. in vitro.
胰岛素在体外能明显刺激骨骼肌蛋白质合成。令人惊讶的是,这种效应在体内却很难重现。由于体外研究通常使用的胰岛素浓度比体内研究高得多,我们研究了这些浓度差异是否能解释体外和体内观察结果之间的差异。在14名健康志愿者中,我们将前臂胰岛素浓度提高到基础水平的1000倍,同时维持4小时血糖正常。给予氨基酸以维持基础动脉(n = 4)或静脉血浆(n = 6)氨基酸水平,或使前臂动脉血浆氨基酸增加100%(n = 4)。我们在基线和胰岛素输注4小时时测量前臂肌肉葡萄糖、乳酸、氧气、苯丙氨酸平衡以及[3H]苯丙氨酸动力学。极度高胰岛素血症强烈逆转了吸收后肌肉的苯丙氨酸平衡,从净释放变为摄取(P < 0.001)。这种显著的合成代谢效应源于蛋白质合成的显著刺激(P < 0.01)以及蛋白质降解的适度下降。此外,即使维持基础动脉或静脉氨基酸血症,这种效应仍然可见。在显著高胰岛素血症时,当血浆氨基酸浓度也增加时,蛋白质合成进一步增加(P < 0.05)。胰岛素和氨基酸联合输注时,前臂血流量至少增加两倍(P < 0.01),且在所有组中均一致。这些结果表明,即使氨基酸浓度不增加,高浓度胰岛素在体内也能显著刺激成年人肌肉蛋白质合成。这与先前的体外报告相似,但与体内生理性高胰岛素血症不同,后者不会刺激蛋白质合成。因此,目前的研究结果表明,先前研究中使用的胰岛素浓度差异可能在很大程度上解释了先前报道的胰岛素对成年肌肉体内与体外蛋白质合成作用之间的差异。